OTCMKTS:FUJIY

Fujifilm Q4 2025 Earnings Report

Fujifilm logo
$10.62 +0.16 (+1.53%)
As of 03:59 PM Eastern

Fujifilm EPS Results

Actual EPS
$0.22
Consensus EPS
$0.18
Beat/Miss
Beat by +$0.04
One Year Ago EPS
N/A

Fujifilm Revenue Results

Actual Revenue
$6.06 billion
Expected Revenue
$822.51 billion
Beat/Miss
Missed by -$816.45 billion
YoY Revenue Growth
N/A

Fujifilm Announcement Details

Quarter
Q4 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Fujifilm's next earnings date is estimated for Wednesday, August 5, 2026, based on past reporting schedules.

Conference Call Resources

Fujifilm Earnings Headlines

Fujifilm Life Sciences at BIO 2026
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
See More Fujifilm Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fujifilm? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fujifilm and other key companies, straight to your email.

About Fujifilm

Fujifilm (OTCMKTS:FUJIY) (OTCMKTS:FUJIY) is a Tokyo-based multinational conglomerate originally founded in 1934 as Fuji Photo Film Co., Ltd. Over the decades the company has evolved from a photographic film manufacturer into a diversified technology group operating across imaging, information, highly functional materials and healthcare. Fujifilm Holdings Corporation serves customers worldwide with a combination of hardware, consumables, software and services.

The company’s product and service portfolio spans consumer and professional imaging products, commercial and industrial printing systems, and office document solutions including printers and copiers. Fujifilm also develops and supplies highly functional materials and components used in electronics and manufacturing, such as specialty films, coatings and display materials. In healthcare and life sciences, the group offers diagnostic imaging systems, endoscopy equipment, in vitro diagnostics, and has a growing presence in pharmaceuticals and biopharmaceutical contract development and manufacturing.

Fujifilm conducts research and development through global R&D centers and operates manufacturing and sales networks across Asia, Europe, the Americas and other regions, supporting both local markets and international customers. The company’s strategy in recent years has emphasized diversification away from traditional photographic film into higher-growth areas such as medical technologies, bioprocessing services and advanced materials, leveraging its chemical and imaging expertise.

As a holdings group, Fujifilm is managed through an executive team based in Tokyo and a portfolio of operating subsidiaries that focus on specific markets and technologies. The company is known for technology-driven partnerships, investments in R&D and an ability to apply core competencies across consumer, industrial and healthcare sectors.

View Fujifilm Profile